BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency.
BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency.
复制标题
BET 抑制剂 RVX-208 和 PFI-1 可重新激活潜伏期的 HIV-1
DOI:
10.1038/s41598-017-16816-1
复制
发表时间:
2017-11-30
影响因子:
4.6
通讯作者:
Zhu H
中科院分区:
文献类型:
--
作者:
Lu P;Shen Y;Yang H;Wang Y;Jiang Z;Yang X;Zhong Y;Pan H;Xu J;Lu H;Zhu H
Persistent latent reservoir in resting CD4+ T cells is a major obstacle in curing HIV-1 infection. Effective strategies for eradication of the HIV-1 reservoir are urgently needed. We report here for the first time that two BET inhibitors, RVX-208, which has entered phase II clinical trials for diverse cardiovascular disorders, and PFI-1, which has been widely studied in oncology, can reactivate HIV-1 from latency. RVX-208 and PFI-1 treatment alone or in combination with other latency reversing agents efficiently reactivated HIV-1 transcription through an up-regulation of P-TEFb by increasing CDK9 Thr-186 phosphorylation in latently infected Jurkat T cellsin vitro. The two BET inhibitors also reactivated HIV-1 transcription in cART treated patient-derived resting CD4+ T cellsex vivo, without influence on global immune cell activation. Our findings, in combination with previous reports, further confirm that BET inhibitors are a group of leading compounds for combating HIV-1 latency for viral eradication.
登录
查看更多内容
DOI:
10.1073/pnas.94.24.13193
发表时间:
1997-11-25
影响因子:
11.1
作者:
Chun, TW;Stuyver, L;Fauci, AS
通讯作者:
Fauci, AS
影响因子:
158.5
作者:
Gulick, RM;Mellors, JW;Chodakewitz, JA
通讯作者:
Chodakewitz, JA
影响因子:
8
作者:
通讯作者:
--
影响因子:
5.5
作者:
Banerjee, Camellia;Archin, Nancie;Montano, Monty
通讯作者:
Montano, Monty
影响因子:
11.4
作者:
Jordan, A;Bisgrove, D;Verdin, E
通讯作者:
Verdin, E